Law360, New York (June 29, 2007, 12:00 AM ET) -- Takeda Pharmaceutical Co. triumphed in the latest in a string of court battles Thursday, when an appeals court panel affirmed a lower court ruling upholding the patent for its blockbuster diabetes treatment Actos.
In its opinion, the U.S. Court of Appeals for the Federal Circuit rejected the obviousness argument put forth by generic drug maker Alphapharm Pty. Ltd.
“Based on the record before us, we conclude that the district court's fact-findings were not clearly erroneous and were supported by evidence in the record,” Judge Alan D....
Federal Circuit Keeps Takeda's Win Streak Alive
To view the full article, take a free trial now.
